L. M. Ojemann

2.2k total citations
38 papers, 1.7k citations indexed

About

L. M. Ojemann is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. M. Ojemann has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Psychiatry and Mental health, 22 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. M. Ojemann's work include Epilepsy research and treatment (28 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Neuroscience and Neuropharmacology Research (7 papers). L. M. Ojemann is often cited by papers focused on Epilepsy research and treatment (28 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Neuroscience and Neuropharmacology Research (7 papers). L. M. Ojemann collaborates with scholars based in United States, Thailand and Australia. L. M. Ojemann's co-authors include Alan J. Wilensky, Mark Holmes, Carl B. Dodrill, George A. Ojemann, Allan S. Troupin, Patrick N. Friel, G. A. Ojemann, Donald L. Dudley, R. A. Buchanan and René H. Levy and has published in prestigious journals such as Neurology, Annals of Neurology and Epilepsia.

In The Last Decade

L. M. Ojemann

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. M. Ojemann United States 26 1.2k 791 585 343 190 38 1.7k
John W. Dailey United States 28 964 0.8× 464 0.6× 1.6k 2.7× 279 0.8× 158 0.8× 50 2.3k
W Löscher Germany 25 945 0.8× 773 1.0× 1.1k 1.9× 155 0.5× 76 0.4× 43 1.9k
Anna Patten United Kingdom 26 923 0.8× 1.3k 1.7× 767 1.3× 167 0.5× 90 0.5× 78 2.2k
Dagmar Hönack Germany 30 1.5k 1.3× 954 1.2× 2.3k 3.9× 273 0.8× 177 0.9× 48 3.1k
Marcus E. Risner United States 21 654 0.6× 547 0.7× 643 1.1× 81 0.2× 178 0.9× 31 1.9k
Pavel Klein United States 29 2.0k 1.7× 1.5k 2.0× 1.3k 2.3× 144 0.4× 122 0.6× 98 2.7k
Elsa M. Valdizán Spain 25 474 0.4× 295 0.4× 867 1.5× 221 0.6× 552 2.9× 57 1.8k
Joseph F. Gardocki United States 18 619 0.5× 386 0.5× 529 0.9× 155 0.5× 246 1.3× 30 1.8k
Yuly Bersudsky Israel 27 916 0.8× 248 0.3× 317 0.5× 132 0.4× 141 0.7× 89 1.8k
Misty D. Smith United States 22 600 0.5× 307 0.4× 848 1.4× 104 0.3× 184 1.0× 40 1.5k

Countries citing papers authored by L. M. Ojemann

Since Specialization
Citations

This map shows the geographic impact of L. M. Ojemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. M. Ojemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. M. Ojemann more than expected).

Fields of papers citing papers by L. M. Ojemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. M. Ojemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. M. Ojemann. The network helps show where L. M. Ojemann may publish in the future.

Co-authorship network of co-authors of L. M. Ojemann

This figure shows the co-authorship network connecting the top 25 collaborators of L. M. Ojemann. A scholar is included among the top collaborators of L. M. Ojemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. M. Ojemann. L. M. Ojemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ojemann, L. M., et al.. (2006). Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy & Behavior. 8(2). 376–383. 155 indexed citations
2.
Holmes, Mark, et al.. (2003). Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes. Seizure. 13(5). 340–345. 61 indexed citations
3.
Vossler, David G., et al.. (2002). Serum and CSF Glutamine Levels in Valproate‐related Hyperammonemic Encephalopathy. Epilepsia. 43(2). 154–159. 60 indexed citations
4.
Holmes, Mark, Donald E. Born, Roman L. Kutsy, et al.. (2000). Outcome after surgery in patients with refractory temporal lobe epilepsy and normal MRI. Seizure. 9(6). 407–411. 77 indexed citations
5.
Holmes, Mark, Roman L. Kutsy, George A. Ojemann, Alan J. Wilensky, & L. M. Ojemann. (2000). Interictal, unifocal spikes in refractory extratemporal epilepsy predict ictal origin and postsurgical outcome. Clinical Neurophysiology. 111(10). 1802–1808. 55 indexed citations
6.
Schachter, Steven C., Blanca Vázquez, Robert S. Fisher, et al.. (1999). Oxcarbazepine. Neurology. 52(4). 732–732. 112 indexed citations
7.
Holmes, Mark, Alan J. Wilensky, L. M. Ojemann, & G. A. Ojemann. (1999). Predicting outcome following reoperation for medically intractable epilepsy. Seizure. 8(2). 103–106. 29 indexed citations
8.
Lin, Yi‐Xin, Gail D. Anderson, Eric D. Kantor, L. M. Ojemann, & Alan J. Wilensky. (1999). Differences in the Urinary Excretion of 6‐β‐Hydroxycortisol/Cortisol between Asian and Caucasian Women. The Journal of Clinical Pharmacology. 39(6). 578–582. 50 indexed citations
9.
Holmes, Mark, Alan J. Wilensky, George A. Ojemann, & L. M. Ojemann. (1999). Hippocampal or neocortical lesions on magnetic resonance imaging do not necessarily indicate site of ictal onsets in partial epilepsy. Annals of Neurology. 45(4). 461–465. 37 indexed citations
10.
Holmes, Mark, Carl B. Dodrill, Robert J. Wilkus, L. M. Ojemann, & George A. Ojemann. (1998). Is Partial Epilepsy Progressive? Ten‐Year Follow‐Up of EEG and Neuropsychological Changes in Adults with Partial Seizures. Epilepsia. 39(11). 1189–1193. 70 indexed citations
11.
Holmes, Mark, Carl B. Dodrill, Alan J. Wilensky, L. M. Ojemann, & G. A. Ojemann. (1996). Unilateral Focal Preponderance of Interictal Epileptiform Discharges as a Predictor of Seizure Origin. Archives of Neurology. 53(3). 228–232. 43 indexed citations
12.
Haglund, Michael M. & L. M. Ojemann. (1993). Seizure Outcome in Patients Undergoing Temporal Lobe Resections for Epilepsy. Neurosurgery Clinics of North America. 4(2). 337–344. 10 indexed citations
13.
Graf, W., S. M. Sumi, Michael K. Copass, et al.. (1993). Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged‐red fiber disease point mutation in mitochondrial DNA. Annals of Neurology. 33(6). 640–645. 25 indexed citations
14.
Jacobs, Bob, et al.. (1993). Quantitative Dendritic and Spine Analyses of Speech Cortices: A Case Study. Brain and Language. 44(3). 239–253. 40 indexed citations
15.
Ojemann, L. M., et al.. (1992). Long-term treatment with gabapentin for partial epilepsy. Epilepsy Research. 13(2). 159–165. 39 indexed citations
16.
Ojemann, L. M., et al.. (1991). Seizures of Fronto‐Orbital Origin: A Proven Case. Epilepsia. 32(4). 487–491. 28 indexed citations
17.
Wilensky, Alan J., Patrick N. Friel, L. M. Ojemann, H. J. Kupferberg, & René H. Levy. (1985). Pharmacokinetics of W‐554 (ADD 03055) in Epileptic Patients. Epilepsia. 26(6). 602–606. 53 indexed citations
18.
Wilensky, Alan J., Patrick N. Friel, L. M. Ojemann, et al.. (1985). Zonisamide in Epilepsy: A Pilot Study. Epilepsia. 26(3). 212–220. 102 indexed citations
19.
Ojemann, L. M. & G. A. Ojemann. (1984). Treatment of epilepsy.. PubMed. 30(2). 113–28. 3 indexed citations
20.
Ojemann, L. M., et al.. (1983). Effect of doxepin on seizure frequency in depressed epileptic patients. Neurology. 33(5). 646–646. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Dailey Breakdown of academic impact, for papers by W Löscher Breakdown of academic impact, for papers by Anna Patten Breakdown of academic impact, for papers by Dagmar Hönack Breakdown of academic impact, for papers by Marcus E. Risner Breakdown of academic impact, for papers by Pavel Klein Breakdown of academic impact, for papers by Elsa M. Valdizán Breakdown of academic impact, for papers by Joseph F. Gardocki Breakdown of academic impact, for papers by Yuly Bersudsky Breakdown of academic impact, for papers by Misty D. Smith
Rankless by CCL
2026